Navigation Links
Abaxis to Present at the 2007 UBS Global Life Science Conference
Date:9/18/2007

UNION CITY, Calif., Sept. 18 /PRNewswire-FirstCall/ -- Abaxis, Inc. (Nasdaq: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, CEO and President, will present at the 2007 UBS Global Life Science Conference on Thursday, September 27, 2007 at 12:00 p.m. Eastern Time at the Grand Hyatt in New York City.

Interested parties can access the webcast of the presentation at http://www.ibb.ubs.com. Click on the conferences icon, then click on the 2007 Global Life Sciences Conference event and the follow the link for the webcast. The replay will be available 3 hours after the actual presentation time, and will be accessible until October 27, 2007.

About Abaxis

Abaxis develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients. The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples. The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer. The veterinary business also provides to the veterinarian and research market a line of hematology instruments for point of care complete blood counts (CBC).

Contact: Clint Severson Lytham Partners,
'/>"/>

SOURCE Abaxis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
2. Researchers Present Ways To Reduce The Risk Of Dementia
3. Researchers Present Data Regarding The Efficiency Of Herbs
4. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
5. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
6. Drug Reactions First Present Themselves In The Mouth
7. Reminiscing Into The Past Makes You Dissatisfied With The Present
8. Living In The Past Indicates Dissatisfaction With Present
9. Movies Represent Coma In A Wrong Way
10. Onchocerciasis: Presentation And Treatment
11. Researchers Warn That Routine Physical Examination Could Miss Breech Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2008)... Open enrollment is now ha... cover expenses not covered by Medicare, and may a...ny consumers are now shopping online for instant q... Fort Collins, CO (PRWEB) November 21, 2008 -- Med...nt for Medicare Supplement plans . Medicare Adva...
(Date:11/21/2008)...inding may lead to new therapies for preterm labor... Researchers say they,ve found the switch that act...childbirth, a finding that may lead to therapies f...normally binds the protein IP on the surface of th...inactive during pregnancy. , But researchers f...
(Date:11/21/2008)..., TALLAHASSEE, Fla. -- A Florida State University... Wang has discovered an important new layer of reg...ad to a greater understanding of the way cancer be...al sciences at the College of Medicine, said the f...se cancer and could lead to the design of new drug...
(Date:11/21/2008)...OVELAND, Colo., Nov. 21 ...ed it will present at the New York Society of,Sec...Pharma Conference on,December 2, 2008 at 1177 Ave...he presentation is scheduled to begin at 9:35 a.m....be available via live webcast and for two weeks,f...
Breaking Medicine News(10 mins):Health News:MediGap Advisors Announces Open Enrollment for Medicare Supplement Plans 2
... a half months after his sexual organ was complete... to lead a normal life again after a Delhi hospita...The unmarried man from Uttar Pradesh underwent a s...he Sir Ganga Rama Hospital (SGRH), a leading priva...
...pproach to drug delivery has been achieved. This i...rong and stable glass made from organic material....he journal Science has reported the advanced proce...nsin-Madison and the National Institute of Standar...
...sh scientist was a consultant for a chemical compa...ossibility of developing cancer in the industry.//...demiologist, who died last year was known for havi... blamed in 1800 for having received $1,500 as dail...
...ian parliamentarians will attend a two-day confere...ple's elected representatives in combating the dis..., a worldwide network of individual parliamentaria...al assembly of Punjab (Pakistan), Pakistan Nationa...
Other Medicine News:Health News:Delhi Hospital Reattaches Amputated Penis 2Health News:Drugs Delivery Revolutionized by Extremely Stable Glass 2
(Date:11/20/2008)...w Jersey American Water has lifted the precaution...following municipalities in Middlesex, Somerset an... , , Dunellen , Edison , ...nfield , , , , Somerset County , ..., Green Brook , Hillsborough , ...
(Date:11/20/2008)...SE III TRIAL SHOW SIGNIFICANT, DECREASES IN P..., IN, FIBROMYALGIA PAT...ium, Nov. 20 /PRNewswire-FirstCall/,-- Jazz Pharm...xt Brussels: UCB),announced today positive prelim...e III pivotal clinical trials of sodium oxybate (J...
(Date:11/20/2008)...lk. It does a body good. And,now it,s doing it ev...,research, scientists at OncoNutrition(TM) have di...ate the body,s own production of antioxidants. , ...to:, http://www.prnewswire.com/mnr/eqwestgroup/361...apies, the chief scientist, Dr. David,Tsai, disco...
(Date:11/20/2008)...ll/ -- Duska Therapeutics,Inc., (OTC Bulletin Bo...its,pivotal Phase 3 ATPace clinical trial protoco...(SPA) procedure with the U.S. Food and Drug Admini...greement with the FDA, Duska intends to initiate a...olled and randomized Phase 3,clinical trial with ...
Breaking Medicine Technology:New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4Nventa Provides Corporate Update and Advancement Plans for HspE7 Hsp 6 11 and Poly ICR 8168 1Nventa Provides Corporate Update and Advancement Plans for HspE7 Hsp 6 11 and Poly ICR 8168 2Nventa Provides Corporate Update and Advancement Plans for HspE7 Hsp 6 11 and Poly ICR 8168 3Nventa Provides Corporate Update and Advancement Plans for HspE7 Hsp 6 11 and Poly ICR 8168 4Nventa Provides Corporate Update and Advancement Plans for HspE7 Hsp 6 11 and Poly ICR 8168 5Nventa Provides Corporate Update and Advancement Plans for HspE7 Hsp 6 11 and Poly ICR 8168 6Nventa Provides Corporate Update and Advancement Plans for HspE7 Hsp 6 11 and Poly ICR 8168 7Nventa Provides Corporate Update and Advancement Plans for HspE7 Hsp 6 11 and Poly ICR 8168 8SEIU DVD Exposes How McCain Care Leaves Seniors Behind 27197 1SEIU DVD Exposes How McCain Care Leaves Seniors Behind 27197 2PreMD Inc Completes Secured Debenture Financing 27193 1PreMD Inc Completes Secured Debenture Financing 27193 2Thousands of Public Health Experts to Address Leading Issues at APHA Annual Meeting Oct 25 29 27190 1Thousands of Public Health Experts to Address Leading Issues at APHA Annual Meeting Oct 25 29 27190 2
....--(BUSINESS WIRE)--Apr 19, 2007 - Othera Pharmace...a, Professor of,Pharmacology and Executive Vice Pr...h Institute at Albany College of Pharmacy,will pr...antithrombotic effect of Othera,s lead compound, O...ms from previous ocular,studies on OT-551 eye drop...
...OAKS, Calif.--(BUSINESS WIRE)--Apr 19, 2007 - Amge...e "145 study", a,randomized, double-blind, placebo...R) (darbepoetin alfa) in 600 previously untreated,...er (SCLC),receiving platinum-containing chemothera...icant difference in risk of death (overall,surviva...
Other Medicine Technology:Othera Pharmaceuticals Announces Upcoming Presentation Based Upon,Expanded Understanding of Lead Compound Mechanism of Action 2Othera Pharmaceuticals Announces Upcoming Presentation Based Upon,Expanded Understanding of Lead Compound Mechanism of Action 3Othera Pharmaceuticals Announces Upcoming Presentation Based Upon,Expanded Understanding of Lead Compound Mechanism of Action 4Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 2Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 3Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 4Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 5Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 6Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 7
Olsen bayonet forceps, designed by Mr. Olsen in a configuration with 3 holes to make them lighter, more flexible, and also to ensure maximum grip for different procedures where there is limited acces
Cushing bayonet.
Angulated, blunt and pointed tips.
Straight, blunt tips.
Medicine Products: